Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

12 treatments under study, led by No Pancreatic Duct Stent Placement

Research Leaders

11 sponsors active, led by Wake Forest University Health Sciences

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 9 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (5)

Trial Status

Completed4
Not Yet Recruiting2
Withdrawn1
Unknown1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (9)

Research Network

Common Treatments

  • No Pancreatic Duct Stent Placement1
  • Necrotizing Pancreatitis Patients Organdysfunction Progression1
  • Double Pigtail Plastic Stent1
  • Pancreatic Duct Stent Placement1
  • Stent Removed By The Conventional Strategy1

Active Sponsors

  • Wake Forest University Health Sciences2
  • AdventHealth1
  • West China Hospital1
  • 3M1
  • Chunling Jiang1

Top Investigators

Related Conditions

  • Acute Pancreatitis2
  • Walled Off Necrosis2
  • Pancreatitis Acute Necrotizing1
  • Walledoff Necrosis1
  • Acute Pancreatic Necrosis1

Activity Timeline